Synthesis and estrogen receptor binding affinities of the major human metabolites of raloxifene (LY139481)

被引：13

作者：

Dodge, JA

Lugar, CW

Cho, S

Osborne, JJ

Phillips, DL

Glasebrook, AL

Frolik, CA

机构：

[1] Lilly Research Laboratories, Eli Lilly and Company, Indianapolis

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1997年 / 7卷 / 08期

关键词：

D O I：

10.1016/S0960-894X(97)00142-X

中图分类号：

R914 [药物化学];

学科分类号：

100701 [药物化学];

摘要：

引用

页码：993 / 996

页数：4

共 21 条

[1]

RALOXIFENE (LY139481 HCL) PREVENTS BONE LOSS AND REDUCES SERUM-CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARIECTOMIZED RATS [J].

BLACK, LJ ;

SATO, M ;

ROWLEY, ER ;

MAGEE, DE ;

BEKELE, A ;

WILLIAMS, DC ;

CULLINAN, GJ ;

BENDELE, R ;

KAUFFMAN, RF ;

BENSCH, WR ;

FROLIK, CA ;

TERMINE, JD ;

BRYANT, HU .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) :63-69

[2]

THE SYNTHESIS OF ARYL-D-GLUCOPYRANOSIDURONIC ACIDS [J].

BOLLENBACK, GN ;

LONG, JW ;

BENJAMIN, DG ;

LINDQUIST, JA .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1955, 77 (12) :3310-3315

[3]

CLEMENS JA, 1983, LIFE SCI, V322, P869

[4]

DAHLPUUSTINEN ML, 1989, DRUG METAB DISPOS, V17, P433

[5]

DODGE JA, 1997, IN PRESS J STEROID B

[6]

DODGE JA, 1994, J LABELLED CMPDS RAD, V36, P43

[7]

Draper MW, 1996, J BONE MINER RES, V11, P835

[8]

Forgue S. T., 1996, Pharmaceutical Research (New York), V13, pS429

[9]

GOTTARDIS MM, 1987, CANCER RES, V47, P4020

[10]

Grese TA, 1996, ANNU REP MED CHEM, V31, P181

← 1 2 3 →